Using a helmet that generates an oscillating magnetic field, worn on the head by the patient while administering the treatment at his home, researchers from the Houston Methodist Neurological Institute have succeeded in reducing the fatal brain tumor of the endometrial tumor by more than one third.

It should be noted that, as a result of an unrelated injury, the 53-year-old died after falling to the head after 5 weeks of treatment, according to a study recently published in Frontaire Onkolje.

He is also reported to have disappeared 31 percent of the tumor mass, during that short period, as his brain autopsy confirmed the rapid response to treatment.

Epidermal tumor, the deadliest form of brain cancer in adults, is often fatal, with life expectancy reaching between a few months and two years.

The researchers documented that in May 2018, the patient was infected with endothelial tumor with a large tumor in the left frontal lobe that extends across the midline to the right frontal lobe. On June 4, 2018, surgery was performed for the patient in which the tumor was drastically removed.

Later on in surgery, the patient underwent radiotherapy, but the results of an MRI in January 2020 showed the progression of the tumor, and at normal rates in this case the patient was likely to survive 3.5 to 3.9 months.

Following approval by the Food and Drug Administration (FDA) of a patient's "euthanasia" with the newly invented "electromagnetic helmet" device, the protocol was also approved by the Board of Institutional Audit of the Houston Methodist Research Institute.

Treatment consists of the intermittent application of an oscillating magnetic field resulting from a permanent magnet rotation in a given frequency identification file and timing pattern.

Treatment was first provided for two hours under supervision at a medical clinic, and subsequent treatments were provided at home with the help of the patient's wife, with a maximum of 6 hours per day.

The oncomagnetic helmet appears deceptively simple, consisting of 3 tumor oscillators that are tightly connected to a helmet and connected to a microprocessor-based electronic control unit powered by a rechargeable battery.

Within 5 weeks, the magnetotherapy was well sustained, the mass and size of the tumor had shrunk by about one third, and contraction appeared to be associated with the treatment dose.

Researchers from the Department of Neurosurgery at Houston Methodist Institute say: "Thanks to the courage of this patient and his family, we were able to test and verify the potential effectiveness of the world's first non-surgical treatment for endometriosis."

Scientists have highlighted the importance of family consent to an autopsy: "The generous consent of the family to allow autopsy after the sudden death of the patient has made an invaluable contribution to further study and development of this potentially effective treatment."

The new treatment opens up promising prospects for the treatment of tumors without surgical intervention or chemo-radiological treatment, which causes side effects affecting patients' health.